Chris Koopmans - 15 Oct 2026 Form 4 Insider Report for Marvell Technology, Inc. (MRVL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Oct 2026, 16:43:53 UTC
Prior SEC filing
13 Oct 2026
Next SEC filing
03 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Christopher Koopmans by Blair Walters as Attorney-in-Fact
Filing notes and source

Key filing fact

Chris Koopmans filed Form 4 for Marvell Technology, Inc. (MRVL) on 16 Oct 2026.

Key facts

  • This page summarizes Chris Koopmans's Form 4 filing for Marvell Technology, Inc. (MRVL).
  • 9 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 16 Oct 2026, 16:43.

Change

  • Previous filing in this sequence was filed on 13 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001676204 Primary reporting owner

Koopmans Chris

Relationship
President and COO
Address
5488 MARVELL LANE, SANTA CLARA
Signature
Christopher Koopmans by Blair Walters as Attorney-in-Fact
Signature date
16 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRVL transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,788
Change %
+1.3%
Price
$0.000000*
Shares after
210,729
Date
15 Oct 2026
Ownership
By Trust
Footnotes
F1
MRVL transaction

Common Stock

Tax liability

Transaction value
Shares
-1,468
Change %
-0.7%
Price
$241.24*
Shares after
209,261
Date
15 Oct 2026
Ownership
By Trust
Footnotes
F1, F2
MRVL transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,077
Change %
+1.9%
Price
$0.000000*
Shares after
213,338
Date
15 Oct 2026
Ownership
By Trust
Footnotes
F1
MRVL transaction

Common Stock

Tax liability

Transaction value
Shares
-2,147
Change %
-1%
Price
$241.24*
Shares after
211,191
Date
15 Oct 2026
Ownership
By Trust
Footnotes
F1, F2
MRVL transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,400
Change %
+1.6%
Price
$0.000000*
Shares after
214,591
Date
15 Oct 2026
Ownership
By Trust
Footnotes
F1
MRVL transaction

Common Stock

Tax liability

Transaction value
Shares
-1,791
Change %
-0.83%
Price
$241.24*
Shares after
212,800
Date
15 Oct 2026
Ownership
By Trust
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRVL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-2,788
Change %
-33%
Price
$0.000000*
Shares after
5,575
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,788
Exercise price
Footnotes
F3, F4
MRVL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-4,077
Change %
-14%
Price
$0.000000*
Shares after
24,462
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,077
Exercise price
Footnotes
F3, F5
MRVL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-3,400
Change %
-9.1%
Price
$0.000000*
Shares after
34,000
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,400
Exercise price
Footnotes
F3, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Footnote F2

Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.

Footnote F4

The remaining Restricted Stock Units shall vest on January 15, 2027 and April 15, 2027.

Footnote F5

The remaining Restricted Stock Units shall vest on January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028 and April 15, 2028.

Footnote F6

The remaining Restricted Stock Units shall vest on January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028, April 15, 2028, July 15, 2028, October 15, 2028, January 15, 2029 and April 15, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .